Literature DB >> 28472853

Genetic Rescue of Mitochondrial and Skeletal Muscle Impairment in an Induced Pluripotent Stem Cells Model of Coenzyme Q10 Deficiency.

Damià Romero-Moya1, Carlos Santos-Ocaña2,3, Julio Castaño1, Gloria Garrabou3,4, José A Rodríguez-Gómez5, Vanesa Ruiz-Bonilla6,7, Clara Bueno1, Patricia González-Rodríguez5,6, Alessandra Giorgetti1, Eusebio Perdiguero6,7, Cristina Prieto1, Constanza Moren-Nuñez3,4, Daniel J Fernández-Ayala2,3, Maria Victoria Cascajo2,3, Iván Velasco8,9, Josep Maria Canals6,10,11,12, Raquel Montero3,13, Delia Yubero13, Cristina Jou3,13, José López-Barneo5,6, Francesc Cardellach3,4, Pura Muñoz-Cánoves6,7,14,15, Rafael Artuch3,13, Plácido Navas2,3, Pablo Menendez1,14,16.   

Abstract

Coenzyme Q10 (CoQ10 ) plays a crucial role in mitochondria as an electron carrier within the mitochondrial respiratory chain (MRC) and is an essential antioxidant. Mutations in genes responsible for CoQ10 biosynthesis (COQ genes) cause primary CoQ10 deficiency, a rare and heterogeneous mitochondrial disorder with no clear genotype-phenotype association, mainly affecting tissues with high-energy demand including brain and skeletal muscle (SkM). Here, we report a four-year-old girl diagnosed with minor mental retardation and lethal rhabdomyolysis harboring a heterozygous mutation (c.483G > C (E161D)) in COQ4. The patient's fibroblasts showed a decrease in [CoQ10 ], CoQ10 biosynthesis, MRC activity affecting complexes I/II + III, and respiration defects. Bona fide induced pluripotent stem cell (iPSCs) lines carrying the COQ4 mutation (CQ4-iPSCs) were generated, characterized and genetically edited using the CRISPR-Cas9 system (CQ4ed -iPSCs). Extensive differentiation and metabolic assays of control-iPSCs, CQ4-iPSCs and CQ4ed -iPSCs demonstrated a genotype association, reproducing the disease phenotype. The COQ4 mutation in iPSC was associated with CoQ10 deficiency, metabolic dysfunction, and respiration defects. iPSC differentiation into SkM was compromised, and the resulting SkM also displayed respiration defects. Remarkably, iPSC differentiation in dopaminergic or motor neurons was unaffected. This study offers an unprecedented iPSC model recapitulating CoQ10 deficiency-associated functional and metabolic phenotypes caused by COQ4 mutation. Stem Cells 2017;35:1687-1703.
© 2017 AlphaMed Press.

Entities:  

Keywords:  COQ4; CRISPR-Cas9; Coenzyme Q10; Dopaminergic and motor neurons; Induced pluripotent stem cell; Skeletal muscle

Mesh:

Substances:

Year:  2017        PMID: 28472853     DOI: 10.1002/stem.2634

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  9 in total

Review 1.  Modeling rare diseases with induced pluripotent stem cell technology.

Authors:  Ruthellen H Anderson; Kevin R Francis
Journal:  Mol Cell Probes       Date:  2018-01-05       Impact factor: 2.365

Review 2.  Current and Emerging Clinical Treatment in Mitochondrial Disease.

Authors:  Rory J Tinker; Albert Z Lim; Renae J Stefanetti; Robert McFarland
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

Review 3.  Coenzyme Q10 deficiencies: pathways in yeast and humans.

Authors:  Agape M Awad; Michelle C Bradley; Lucía Fernández-Del-Río; Anish Nag; Hui S Tsui; Catherine F Clarke
Journal:  Essays Biochem       Date:  2018-07-20       Impact factor: 8.000

4.  Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions.

Authors:  Clara Bueno; Fernando J Calero-Nieto; Xiaonan Wang; Rafael Valdés-Mas; Francisco Gutiérrez-Agüera; Heleia Roca-Ho; Veronica Ayllon; Pedro J Real; David Arambilet; Lluis Espinosa; Raul Torres-Ruiz; Antonio Agraz-Doblas; Ignacio Varela; Jasper de Boer; Anna Bigas; Bertie Gottgens; Rolf Marschalek; Pablo Menendez
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941

Review 5.  Gaining Insight into Mitochondrial Genetic Variation and Downstream Pathophysiology: What Can i(PSCs) Do?

Authors:  Jesse D Moreira; Deepa M Gopal; Darrell N Kotton; Jessica L Fetterman
Journal:  Genes (Basel)       Date:  2021-10-22       Impact factor: 4.096

Review 6.  Primary Coenzyme Q10 Deficiency-7 and Pathogenic COQ4 Variants: Clinical Presentation, Biochemical Analyses, and Treatment.

Authors:  Jieqiong Xie; Jiayang Jiang; Qiwei Guo
Journal:  Front Genet       Date:  2022-01-26       Impact factor: 4.599

7.  Electrophysiological Properties of Induced Pluripotent Stem Cell-Derived Midbrain Dopaminergic Neurons Correlate With Expression of Tyrosine Hydroxylase.

Authors:  Aleksandar Rakovic; Dorothea Voß; Franca Vulinovic; Britta Meier; Ann-Katrin Hellberg; Carla Nau; Christine Klein; Enrico Leipold
Journal:  Front Cell Neurosci       Date:  2022-03-23       Impact factor: 5.505

8.  Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells.

Authors:  Paolo Petazzi; Raul Torres-Ruiz; Antonella Fidanza; Heleia Roca-Ho; Francisco Gutierrez-Agüera; Julio Castaño; Sandra Rodriguez-Perales; Rafael Díaz de la Guardia; Belén López-Millán; Anna Bigas; Lesley M Forrester; Clara Bueno; Pablo Menéndez
Journal:  Mol Ther Nucleic Acids       Date:  2020-02-27       Impact factor: 8.886

Review 9.  Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson's Disease Drug Development.

Authors:  S A Antonov; E V Novosadova
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.